957 filings
Page 10 of 48
8-K
rfqb94pvl3j04ow96utw
22 Jun 18
Departure of Directors or Certain Officers
4:02pm
4
qgqsq768 mwcroi1se
22 Jun 18
IMMUNOGEN / Stuart A Arbuckle ownership change
2:21pm
4
uqmuenqz1pjj0jqyl7r
22 Jun 18
IMMUNOGEN / Mark Alan Goldberg ownership change
2:17pm
4
l4vgi8fhtj8jzv
22 Jun 18
IMMUNOGEN / DEAN J MITCHELL ownership change
2:17pm
4
1y2bz
22 Jun 18
IMMUNOGEN / Richard John Wallace ownership change
2:16pm
4
9l2qj
22 Jun 18
IMMUNOGEN / Kristine Peterson ownership change
2:16pm
4
pdbo4
22 Jun 18
IMMUNOGEN / STEPHEN C MCCLUSKI ownership change
2:07pm
8-K
c35hrqvb0 jwco5adq
21 Jun 18
ImmunoGen Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
8:27am
8-K
6es2bkwsfrf4nxic0c
11 Jun 18
ImmunoGen Announces Closing of Public Offering of Common Stock
4:13pm
CT ORDER
jrt23 vtf5
11 Jun 18
Confidential treatment order
11:56am
4
9ezxed
8 Jun 18
IMMUNOGEN / David Brannon Johnston ownership change
4:08pm
8-K
qji0j
7 Jun 18
Entry into a Material Definitive Agreement
4:35pm
424B5
ilaxu9
7 Jun 18
Prospectus supplement for primary offering
4:31pm
424B5
5spc 0lpb58
5 Jun 18
Prospectus supplement for primary offering
5:17pm
S-8
rur 4bd9yh12wqrhd
30 May 18
Registration of securities for employees
3:09pm
CT ORDER
a0l1ktzkgb gctz2
23 May 18
Confidential treatment order
11:07am
8-K
2ruw5t1
17 May 18
Data from Avastin Cohort to be Presented at 2018 ASCO Annual Meeting
7:50am
8-K
vpfju svh2w7
4 May 18
ImmunoGen Reports Recent Progress and First Quarter 2018 Operating Results
6:36am